{"name":"KinoPharma Inc.","slug":"kinopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KNP2002","genericName":"KNP2002","slug":"knp2002","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"KNP2002","genericName":"KNP2002","slug":"knp2002","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxNeUpIQXNZVy04VUptaGd1dDRMa1YwWjRHQTdsUXg2R1RuV0xlX2g5M1diZFpXNmszX1pIMjJ6SERvcmpaN1RlRmtBSWtITVVMVERMcU55UHVsZzUxTDRoVVhsZ3lpQmJVM2psYzRWZ0ZzbTF1YzJKcUM2WDRXNlJtQTZOb1NXSDJkUW9kZl9iUXE0SDNMX2htMklDd2dGNmlCbkN1c2ZpOVp2VlNzZzItS1ZBSUstclUyQ1IxcHVKYTkwUDQxRl94eVRLZnlRVEN2RGtBbnkyalNINEJucV96Vy1XTXpDWk9IdGdPdWVOVkZadGVvY21hYlRGLTdJSklnNGpuSmNKX0ZwcTJuSmJtbmJhQUtrTmthQkVINmtoWFVUWEU1ZmJZU1IwTklKX3N4Tm5rVGtuN1NMQWFqbFQ1YXh2dVZmWENTemthWm1IZw?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight -","headline":"Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeut","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNTlNUMDVON0lvSzhreTBCd04xVzFyRk5rZ2VKYUxxWTA1YWpkQU8yS1FNakotc3B5MkkybUdhc2s2XzNtR2FFWndOaHZFb0NMbzNRbUoteVEyV0hUTjdwZ3BmN3dwUzAxVUdWck5JOWNCMWdBWEs3RUNFUjlwVkVGenZ0Sk5SanR6SkRLaDZhdU9zNEtHR3c?oc=5","date":"2026-04-06","type":"earnings","source":"openPR.com","summary":"Common Warts Market: Expanding Revenue Landscape to 2034 - DelveInsight - openPR.com","headline":"Common Warts Market: Expanding Revenue Landscape to 2034 - DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPdmVtWXVSTS1zR3BtVTJ4SVRwZlp1SUlKWHV6emJRUWtfa0IyWEtsS0lCS25VMUFMck9JMUNldXhqYjBwaE5KOWh3SEpMZHE3LWZiVlVaVWpZSEZjWHd1ajlnc1Y0eUMwTjV2YTA2Z3R4RGt0dGZYVnl1Ylp5YWJVeV9JOTB2ZWdnZjhPM1U3T09hQ1FGMFl1aUdFZmgzUDJoMng0a1FWWjRFSEFIckZIQWhTNVRvRWk3V09kdG10WnBKYm1LR1hCbTJoR2Z2eE5NMG1TLU9tZWpZWlBWXzZrZVo4ckwzS3g5MVow?oc=5","date":"2024-07-04","type":"trial","source":"PR Newswire","summary":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQYXdLT1dibnQzMHp5Sl9keDNYTkFvYXREd2tlR2VEWTJ1ZVJUS0Jkb0p4QkJqOUlCMklLcVlpejF4R3o5TE1OZXhzUVNiTkE4YnJSZ0ZkbWV5b0dYWW1ENkcwYlI3UXAzWFJ6WnQzaUtqOXROX1lMc3JfWXBQWUphYUNzSGhnbnBaM3c?oc=5","date":"2023-04-10","type":"trial","source":"Clinical Trials Arena","summary":"KinoPharma, IWAKI SEIYAKU start Phase II study of cutaneous warts drug - Clinical Trials Arena","headline":"KinoPharma, IWAKI SEIYAKU start Phase II study of cutaneous warts drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}